Innovision IPO opens for subscription on March 10, 2026, and closes on March 12, 2026, with an issue size of ₹323 crore comprising a fresh issue of ₹255 crore and offer for sale of ₹68 crore (58.91 lakh equity shares priced at ₹521 – ₹548) for BSE and NSE mainboard listing on March 17. Noida-based Innovision Ltd delivers IT consulting, software development, and digital transformation services across BFSI, healthcare, and enterprise verticals since 2012. Innovision IPO proceeds support technology infrastructure investments, talent acquisition initiatives, and international market expansion strategies.
₹00
₹548
₹
Expert Opinions
Market sentiment surrounding Innovision IPO appears cautiously optimistic among IT services investors, reflecting rapid revenue scaling from ₹257 crore in FY23 to ₹895 crore in FY25 despite thin margins noted in analyst reviews. Company strengths include nationwide manpower deployment across 20+ states, diversified revenue from toll management government training contracts, 40.77% ROCE efficiency, established enterprise relationships, and scalable labor-intensive operations.
Risks and challenges feature 3.25% PAT margins vulnerable to contract renewals, 92% debt/equity leverage, government dependency exceeding 60% revenues, wage inflation pressures, and competition from larger staffing firms. Valuation analysis of Innovision IPO and year 2025 demonstrates Return on Equity (ROE) of 35.45%, ROCE of 40.77%, and Net Asset Value (NAV) of ₹43.32, priced at 32-35x P/E below sector average of 56x. Long-term investment perspective captures 12% IT staffing CAGR through digital transformation mandates.
Investor Considerations
Innovision IPO demonstrates robust company performance and fundamentals in FY25, scaling revenue 75% to ₹895 crore through diversified manpower deployment, toll management, and government training contracts across 20+ states. IT staffing and consulting sector outlook sustains 12% CAGR fueled by digital transformation mandates and enterprise modernization initiatives. IPO Valuation of Financial Year 2025 for Innovision IPO and year reveals Price to Book Value of 12.65, PAT Margin of 3.25%, and Debt/Equity of 0.97, positioned at 32-35x P/E below industry average reflecting execution leverage.
Growth prospects capitalize on technology infrastructure investments, international expansion targeting BFSI healthcare verticals, and recurring contract renewals with enterprises. Risk factors encompass thin margins susceptible to wage inflation, 60%+ government revenue dependency, working capital strains from receivables, talent retention challenges, and competition from larger IT services firms. Short-term investment goals track listing momentum from IT recovery themes, while long-term visions compound through digital services penetration and client diversification.
| Date | GMP | Trend |
|---|---|---|
| 10 Mar 2026 21.24 | ₹00 | --- |
| 08 Mar 2026 17.52 | ₹00 | --- |
FAQs
Innovision IPO Current GMP is ₹00.
Innovision IPO Expected Returns is 0.00%.
Innovision IPO estimated listing price is ₹548.